跳至主要内容
临床试验/NCT04696172
NCT04696172已完成不适用

Explore Potential Plasma Biomarkers of Acute Respiratory Distress Syndrome (ARDS) Using Proteomics Analysis in Patients Undergoing Cardiopulmonary Bypass

Huazhong University of Science and Technology2 个研究点 分布在 1 个国家目标入组 525 人开始时间: 2021年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
525
试验地点
2
主要终点
Number of participants with postoperative ARDS events as assessed by Berlin Definition.

研究概览

简要总结

The investigators aimed to establish a prospective cohort of patients undergoing cardiopulmonary bypass (CPB) in cardiac surgery from April 2021 to September 2022, in Wuhan. The ARDS events, ventilation time, time of extubation, oxygenation index for 3 days after operation were observed. Plasma samples were collected before CPB, and several time points after CPB. Dynamic differential proteins of ARDS after CPB were screened by DIA (Data independent acquisition) proteomics. Quantitative protein marker concentration was used to predict the occurrence of ARDS after operation, the model discrimination and calibration was assessed.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Selective operation;
  • Cardiac surgery with cardiopulmonary bypass;
  • Adult patients over 18 years old;
  • Signed informed consent

排除标准

  • patients who refuse to sign the informed consent form or the attending physician refuses the patient to join the study;
  • non elective surgery (surgery at non-elective time or emergency surgery);
  • preoperative pulmonary insufficiency, pulmonary hypertension and pulmonary inflammation;
  • the absence of any specimen and clinical data;
  • patients who failed the operation, needed extracorporeal membrane oxygenation support or underwent CPB operation again within 3 days after operation;

结局指标

主要结局

Number of participants with postoperative ARDS events as assessed by Berlin Definition.

时间窗: 3 days after operation

The Berlin Definition of Acute Respiratory Distress Syndrome: 1. Timing: Within 1 week of a known clinical insult or new or worsening respiratory symptoms; 2. Chest imaging: Bilateral opacities-not fully explained by effusions, lobar/lung collapse, or nodules; 3. Origin of edema: Respiratory failure not fully explained by cardiac failure or fluid overload. Need objective assessment (eg, echocardiography) to exclude hydrostatic edema if no risk factor present; 4. Oxygenation: Mild 200 mm Hg \<PaO2/FIO2≤ 300 mm Hg with PEEP or CPAP ≥5 cm H2O; Moderate 100 mm Hg \<PaO2/FIO2≤ 200 mm Hg with PEEP ≥5 cm H2O Severe PaO2/FIO2≤ 100 mm Hg with PEEP ≥5 cm H2O

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Shanglong Yao

Clinical Professor

Wuhan Union Hospital, China

研究点 (2)

Loading locations...

相似试验

Plasma Biomarkers of Cardiopulmonary Bypass Induced... | 临床试验